Focal cortical dysplasia

• Magnetic Resonance-guided Laser interstitial thermal therapy (MR-gLiTT) in Pediatric Neurosurgery: italian perspective and literature review
• Anatomical-electroclinical phenotypes and SEEG-defined network patterns in pure insular lobe epilepsy: A study of 20 cases
• Age at onset of epilepsy shapes neurocognitive profiles in focal cortical dysplasia
• ILAE neuroimaging task force highlight: MRI detection of early life epilepsy caused by focal cortical dysplasia
• Critical contributions of neuronal subtypes to pediatric drug-resistant focal dysplasia
• Spatiotemporal Expression of IRS-1 During Brain Development and its Role in Neural Stem Cell Differentiation
• Beyond the AJR: Melding Artificial Intelligence and MRI to Find Focal Cortical Dysplasia
• Single-cell genotyping and transcriptomic profiling of mosaic focal cortical dysplasia

Focal cortical dysplasia (FCD) was first described as a distinct neuropathological entity in 1971 by Taylor and colleagues. FCD is thought to be an embryological migration disorder and is thus considered a non-progressive, unchangeable disease throughout life ¹⁾.

Focal cortical dysplasia is a malformation of cortical development, which is the most common cause of drug resistant epilepsy in the pediatric population ²⁾.

see Focal cortical dysplasia epidemiology.

see Focal cortical dysplasia classification.

Focal cortical dysplasia pathogenesis

see Focal cortical dysplasia diagnosis.

see Focal cortical dysplasia treatment.

see Focal cortical dysplasia outcome.

see Focal cortical dysplasia case series.

Focal cortical dysplasia case reports.